Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
Status:
Terminated
Trial end date:
2000-03-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the effect of intravenous immunoglobulin on recovery time of
patients with proximal diabetic neuropathy.
II. Determine whether rate of response is dose dependent in these patients.